Letter to the Editor

Split Viewer

Blood Res 2014; 49(3):

Published online September 25, 2014

https://doi.org/10.5045/br.2014.49.3.205

© The Korean Society of Hematology

Second case of postpartum acquired hemophilia A in a Korean female

Kun Soo Lee1*, Ye Jee Shim2, Kyoung Mi Jang1, and Shin Young Hyun3

1Department of Pediatrics, Kyungpook National University Hospital and Kyungpook National University School of Medicine, Daegu, Korea.

2Hanyoung Children's Hospital, Daegu, Korea.

3Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.

Correspondence to : Kun Soo Lee. Department of Pediatrics, Kyungpook National University Hospital and School of Medicine, 130 Dongdukro, Jung-gu, Daegu 700-721, Korea. kslee@knu.ac.kr

Received: August 6, 2014; Revised: August 22, 2014; Accepted: September 19, 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

  1. Collins, PW, Hirsch, S, Baglin, TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood, 2007;109;1870-1877.
    Pubmed
  2. Yee, TT, Taher, A, Pasi, KJ, Lee, CA. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol, 2000;22;275-278.
    Pubmed
  3. Huth-Kuhne, A, Baudo, F, Collins, P, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica, 2009;94;566-575.
    Pubmed
  4. Tengborn, L, Baudo, F, Huth-Kuhne, A, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG, 2012;119;1529-1537.
    Pubmed
  5. Lee, JH, Kim, DH, Yoo, K, Choi, Y, Kim, SH, Kim, HJ. The first case of postpartum acquired hemophilia A in Korea. J Korean Med Sci, 2011;26;1247-1249.
    Pubmed
  6. Sallah, S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia, 2004;10;169-173.
    Pubmed
  7. Sumner, MJ, Geldziler, BD, Pedersen, M, Seremetis, S. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia, 2007;13;451-461.
    Pubmed
  8. Aledort, LM. Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues. Haemophilia, 2008;14;39-43.
    Pubmed
  9. Abshire, T, Kenet, G. Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors. Haemophilia, 2008;14;898-902.
    Pubmed
  10. Lee, YS, Ng, HJ. Mycophenolate in the remission induction of a patient with acquired haemophilia A. Haemophilia, 2010;16;180-182.
    Pubmed
  11. Petrovic, M, Derom, E, Baele, G. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies. Haematologica, 2000;85;895-896.
    Pubmed
  12. Hauser, I, Schneider, B, Lechner, K. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost, 1995;73;1-5.
    Pubmed
  13. Coller, BS, Hultin, MB, Hoyer, LW, et al. Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood, 1981;58;619-624.
    Pubmed
  14. Baudo, F, de Cataldo, F. Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice. BJOG, 2003;110;311-314.
    Pubmed

Article

Letter to the Editor

Blood Res 2014; 49(3): 205-207

Published online September 25, 2014 https://doi.org/10.5045/br.2014.49.3.205

Copyright © The Korean Society of Hematology.

Second case of postpartum acquired hemophilia A in a Korean female

Kun Soo Lee1*, Ye Jee Shim2, Kyoung Mi Jang1, and Shin Young Hyun3

1Department of Pediatrics, Kyungpook National University Hospital and Kyungpook National University School of Medicine, Daegu, Korea.

2Hanyoung Children's Hospital, Daegu, Korea.

3Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.

Correspondence to: Kun Soo Lee. Department of Pediatrics, Kyungpook National University Hospital and School of Medicine, 130 Dongdukro, Jung-gu, Daegu 700-721, Korea. kslee@knu.ac.kr

Received: August 6, 2014; Revised: August 22, 2014; Accepted: September 19, 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    References

    1. Collins, PW, Hirsch, S, Baglin, TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood, 2007;109;1870-1877.
      Pubmed
    2. Yee, TT, Taher, A, Pasi, KJ, Lee, CA. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol, 2000;22;275-278.
      Pubmed
    3. Huth-Kuhne, A, Baudo, F, Collins, P, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica, 2009;94;566-575.
      Pubmed
    4. Tengborn, L, Baudo, F, Huth-Kuhne, A, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG, 2012;119;1529-1537.
      Pubmed
    5. Lee, JH, Kim, DH, Yoo, K, Choi, Y, Kim, SH, Kim, HJ. The first case of postpartum acquired hemophilia A in Korea. J Korean Med Sci, 2011;26;1247-1249.
      Pubmed
    6. Sallah, S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia, 2004;10;169-173.
      Pubmed
    7. Sumner, MJ, Geldziler, BD, Pedersen, M, Seremetis, S. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia, 2007;13;451-461.
      Pubmed
    8. Aledort, LM. Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues. Haemophilia, 2008;14;39-43.
      Pubmed
    9. Abshire, T, Kenet, G. Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors. Haemophilia, 2008;14;898-902.
      Pubmed
    10. Lee, YS, Ng, HJ. Mycophenolate in the remission induction of a patient with acquired haemophilia A. Haemophilia, 2010;16;180-182.
      Pubmed
    11. Petrovic, M, Derom, E, Baele, G. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies. Haematologica, 2000;85;895-896.
      Pubmed
    12. Hauser, I, Schneider, B, Lechner, K. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost, 1995;73;1-5.
      Pubmed
    13. Coller, BS, Hultin, MB, Hoyer, LW, et al. Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood, 1981;58;619-624.
      Pubmed
    14. Baudo, F, de Cataldo, F. Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice. BJOG, 2003;110;311-314.
      Pubmed
    Blood Res
    Volume 59 2024

    Stats or Metrics

    Share this article on

    • line

    Blood Research

    pISSN 2287-979X
    eISSN 2288-0011
    qr-code Download